Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × cabazitaxel × Clear all

NCT02560337 2020-10-08

CaTo-ROC

Phase 2 Completed

Ovarian Neoplasms, Recurrence

NCT01747239 2014-12-04

Cabazitaxel in Platinum Refractory Ovarian Cancer

Phase 2 Terminated

Ovarian Neoplasms